(Q54351691)

28 May 2018

title

mTORC1 activation triggers the unfolded protein response in podocytes and leads to nephrotic syndrome. (English)

1 reference

28 May 2018

author name string

Noriko Ito

1

1 reference

28 May 2018

Yukino Nishibori

2

1 reference

28 May 2018

Yugo Ito

3

1 reference

28 May 2018

Hisashi Takagi

4

1 reference

28 May 2018

Yoshihiro Akimoto

5

1 reference

28 May 2018

Akihiko Kudo

6

1 reference

28 May 2018

Katsuhiko Asanuma

7

1 reference

28 May 2018

Yoshimichi Sai

8

1 reference

28 May 2018

Ken-Ichi Miyamoto

9

1 reference

28 May 2018

Hitoshi Takenaka

10

1 reference

28 May 2018

Kunimasa Yan

11

1 reference

28 May 2018

publication date

29 August 2011

1 reference

28 May 2018

published in

Laboratory Investigation

1 reference

28 May 2018

volume

91

1 reference

28 May 2018

issue

11

1 reference

28 May 2018

page(s)

1584-1595

1 reference

28 May 2018

https://scigraph.springernature.com/pub.10.1038/labinvest.2011.135

exact match

0 references

cites work

Molecular mechanisms of mTOR-mediated translational control

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.135

Endoplasmic reticulum stress responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.135

Protein quality control in the early secretory pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.135

Quality and quantity control at the endoplasmic reticulum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.135

ER chaperones in mammalian development and human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.135

Endoplasmic reticulum stress in proteinuric kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.135

Endoplasmic reticulum stress and renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.135

Minimal change nephropathy and focal segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.135

Positionally cloned gene for a novel glomerular protein--nephrin--is mutated in congenital nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.135

Structure of the gene for congenital nephrotic syndrome of the finnish type (NPHS1) and characterization of mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.135

N-linked glycosylation is critical for the plasma membrane localization of nephrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.135

The effect of dexamethasone on defective nephrin transport caused by ER stress: a potential mechanism for the therapeutic action of glucocorticoids in the acquired glomerular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.135

21 January 2018

Expanding mTOR signaling

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.135

Amino acid availability regulates p70 S6 kinase and multiple translation factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.135

mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.135

Upstream and downstream of mTOR

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.135

Expression of galectin-1, a new component of slit diaphragm, is altered in minimal change nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.135

Amino acid transporter LAT3 is required for podocyte development and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.135

Role of amino acid transporter LAT2 in the activation of mTORC1 pathway and the pathogenesis of crescentic glomerulonephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.135

AMP-activated protein kinase: the energy charge hypothesis revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.135

Endoplasmic reticulum: nutrient sensor in physiology and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.135

The endoplasmic reticulum and the unfolded protein response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.135

Role of the endoplasmic reticulum unfolded protein response in glomerular epithelial cell injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.135

Novel serpinopathy in rat kidney and pancreas induced by overexpression of megsin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.135

TOR signaling: an odyssey from cellular stress to the cell growth machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.135

Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.135

mTOR regulates expression of slit diaphragm proteins and cytoskeleton structure in podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.135

Rapamycin has dual opposing effects on proteinuric experimental nephropathies: is it a matter of podocyte damage?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.135

Comparative analysis of adverse events requiring suspension of mTOR inhibitors: everolimus versus sirolimus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.135

Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.135

Loss of the tuberous sclerosis complex tumor suppressors triggers the unfolded protein response to regulate insulin signaling and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.135

The podocyte as a direct target of immunosuppressive agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.135

Orchestrating the unfolded protein response in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.135

inferred from DOI database lookup

7 January 2021

based on heuristic

Mizoribine Corrects Defective Nephrin Biogenesis by Restoring Intracellular Energy Balance

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.135

inferred from DOI database lookup

7 January 2021

based on heuristic

Proinflammatory effects in experimental mesangial proliferative glomerulonephritis of the immunosuppressive agent SDZ RAD, a rapamycin derivative

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.135

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/LABINVEST.2011.135

1 reference

28 May 2018

PubMed ID

21876538

1 reference

28 May 2018